Download presentation
Presentation is loading. Please wait.
Published byDebra Daniel Modified over 9 years ago
1
Caitlin Cleary Biochemistry Spring ‘12
2
What is it? A type of arteriosclerosis characterized by changes in the endothelial lining and the formation of a plaque Occurs in people whose blood contains elevated levels of plasma lipids, such as cholesterol Causes chest pain, heart attack, and stroke Can lead to coronary artery disease
3
How does it occur?
4
Inflammation Promotes initiation and development of atherosclerosis, and therefore contributes to fast forming acute blood clots Inflammation can be triggered by: Infection Obesity Hypertension
5
Who is at risk? Everyone! By the time young adults reach their 30s, some degree of atherosclerosis has developed in 80 to 90% of people in the united states Nearly 50% of the US population has elevated LDL cholesterol
6
Prevention Start monitoring for risk factors in adolescents Fasting Lipid Profile Evaluate for hypertension Screen for diabetes Screen for metabolic syndrome Therapeutic Lifestyle Changes Diet Physical activity Cessation of smoking
7
Current Treatments Dietary supplements and herbal preparations are questionable LDL Cholesterol-Lowering Therapies Statins Ezetimibe Eicosapentaenoic acid from Fish Oil Niacin
8
Future Treatment? Oral Anit-CD3 Antibody Treatment Study Treated mice with 5 microgram dosage of anti-CD3 antibody for 5 days 50% reduction in lesion formation 38% reduction in accumulation of macrophages 30% decrease in T-cell infiltration
9
Works Cited Campbell, Mary K., & Farrell, Shawn O. (2012). Biochemistry. Belmont, CA: Brooks/Cole. Lewis, Sandra J. (2009). Prevention and Treatment of Atherosclerosis: A Practitioner’s Guide for 2008. The American Journal of Medicine, 122(1A), 38-50. Libby, Peter., Ridker, Paul M., & Maseri, Attilio. (2002). Inflammation and Atherosclerosis. Journal of the American Heart Association, 105, 1135-1143. Sasaki, Naoto., Yamashita, Tomoya., Takeda, Masafumi., Shinohara, Masakazu., Nakajima, Kenji., Tawa, Hideto., et al. (2009). Oral Anti-CD3 Antibody Treatment Reduces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice. Journal of the American Heart Association, 120, 1996-2005.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.